SUPERNUS PHARMACEUTICALS INC (SUPN)

US8684591089 - Common Stock

35.43 -0.34 (-0.95%)

After market: 35.43 0 (0%)

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 80% to SUPN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 40.04. This target is 13% above the current price.

SUPN was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SUPN.

In the previous month the buy percentage consensus was at a similar level.

SUPN was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

35.43

36.36

39.78

40.04

45.15

2.62%

12.28%

13.00%

27.43%

Up and Down Grades

Date	Firm	Action	Rating
2024-09-11	Piper Sandler	Downgrade	Overweight -> Neutral
2024-02-28	Piper Sandler	Maintains	Overweight -> Overweight
2023-11-09	Piper Sandler	Maintains	Overweight -> Overweight
2023-10-25	Piper Sandler	Maintains	Overweight -> Overweight
2023-05-10	Piper Sandler	Maintains	Overweight -> Overweight
2023-01-23	Piper Sandler	Maintains	Overweight
2022-08-31	Piper Sandler	Maintains	Overweight
2021-04-13	Jefferies	Upgrade	Hold -> Buy